Vault-13

Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2024-11-14

SEC-registered investment adviser since 2014 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 11
Palo Alto, CAUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.9bn reported value +21.6% vs Q2 2024
38positions
65.6%in top 10
4 new 5 added 6 reduced 1 sold out vs Q2 2024

Holdings, Q3 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 APOGEE THERAPEUTICS INC COM COM 8,493,321 $498.9m26.13% 26.13% UnchangedShares held: Q4 2023 8.5m, Q1 2024 8.5m, Q2 2024 8.5m, Q3 2024 8.5m
2 OCULAR THERAPEUTIX INC COM OCUL OCUL 12,762,462 $111.0m5.82% 5.82% UnchangedShares held: Q4 2023 7.8m, Q1 2024 12.8m, Q2 2024 12.8m, Q3 2024 12.8m
3 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 4,026,331 $102.8m5.39% 5.39% UnchangedShares held: Q4 2023 3.0m, Q1 2024 4.0m, Q2 2024 4.0m, Q3 2024 4.0m
4 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 3,882,709 $88.3m4.63% 4.63% AddedShares held: Q4 2023 3.9m, Q1 2024 3.9m, Q2 2024 3.9m, Q3 2024 3.9m +38 +38 0.0%
5 APPLIED THERAPEUTICS INC COM APLT APLT 9,825,000 $83.5m4.37% 4.37% AddedShares held: Q4 2023 6.2m, Q1 2024 9.1m, Q2 2024 9.5m, Q3 2024 9.8m +282.1k +282,129 3.0%
6 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 2,685,448 $79.0m4.14% 4.14% UnchangedShares held: Q4 2023 2.4m, Q1 2024 2.2m, Q2 2024 2.7m, Q3 2024 2.7m
7 DYNE THERAPEUTICS INC COM DYN DYN 2,173,913 $78.1m4.09% 4.09% UnchangedShares held: Q4 2023 2.2m, Q1 2024 2.2m, Q2 2024 2.2m, Q3 2024 2.2m
8 ORUKA THERAPEUTICS INC COM ORKA ORKA 3,085,620 $75.6m3.96% 3.96% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 3.1m
9 KALVISTA PHARMACEUTICALS INC COM KALV KALV 6,249,731 $72.4m3.79% 3.79% UnchangedShares held: Q4 2023 4.1m, Q1 2024 6.2m, Q2 2024 6.2m, Q3 2024 6.2m
10 PHARVARIS N V COM PHVS PHVS 3,395,606 $62.9m3.29% 3.29% UnchangedShares held: Q4 2023 3.4m, Q1 2024 3.4m, Q2 2024 3.4m, Q3 2024 3.4m
11 COGENT BIOSCIENCES INC COM COGT COGT 5,684,167 $61.4m3.22% 3.22% UnchangedShares held: Q4 2023 4.7m, Q1 2024 5.1m, Q2 2024 5.7m, Q3 2024 5.7m
12 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 1,744,373 $47.8m2.50% 2.50% ReducedShares held: Q4 2023 927.7k, Q1 2024 2.1m, Q2 2024 2.1m, Q3 2024 1.7m -350.0k -350,000 -16.7%
13 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 4,400,000 $47.6m2.49% 2.49% UnchangedShares held: Q4 2023 3.4m, Q1 2024 4.4m, Q2 2024 4.4m, Q3 2024 4.4m
14 MERUS N V COM MRUS MRUS 907,963 $45.4m2.38% 2.38% ReducedShares held: Q4 2023 2.1m, Q1 2024 1.8m, Q2 2024 1.3m, Q3 2024 908.0k -355.3k -355,251 -28.1%
15 ORIC PHARMACEUTICALS INC COM ORIC ORIC 4,394,527 $45.0m2.36% 2.36% UnchangedShares held: Q4 2023 2.4m, Q1 2024 4.4m, Q2 2024 4.4m, Q3 2024 4.4m
16 ERASCA INC COM ERAS ERAS 16,216,216 $44.3m2.32% 2.32% UnchangedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 16.2m, Q3 2024 16.2m
17 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 706,131 $40.6m2.13% 2.13% UnchangedShares held: Q4 2023 353.6k, Q1 2024 706.1k, Q2 2024 706.1k, Q3 2024 706.1k
18 ASTRIA THERAPEUTICS INC COM CATB CATB 3,458,645 $38.1m1.99% 1.99% ReducedShares held: Q4 2023 3.2m, Q1 2024 3.6m, Q2 2024 3.6m, Q3 2024 3.5m -150.0k -150,000 -4.2%
19 TERNS PHARMACEUTICALS INC COM COM 3,410,058 $28.4m1.49% 1.49% UnchangedShares held: Q4 2023 4.5m, Q1 2024 3.4m, Q2 2024 3.4m, Q3 2024 3.4m
20 AQUESTIVE THERAPEUTICS INC COM AQST AQST 5,555,555 $27.7m1.45% 1.45% UnchangedShares held: Q4 2023 0, Q1 2024 5.6m, Q2 2024 5.6m, Q3 2024 5.6m
21 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 1,000,000 $26.7m1.40% 1.40% ReducedShares held: Q4 2023 0, Q1 2024 1.8m, Q2 2024 1.8m, Q3 2024 1.0m -818.2k -818,182 -45.0%
22 ARTIVA BIOTHERAPEUTICS INC COM ARTV ARTV 1,609,569 $24.9m1.30% 1.30% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 1.6m
23 ENGENE HOLDINGS INC COM COM 3,565,841 $23.5m1.23% 1.23% AddedShares held: Q4 2023 0, Q1 2024 2.6m, Q2 2024 2.8m, Q3 2024 3.6m +739.9k +739,858 26.2%
24 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,379,965 $23.1m1.21% 1.21% UnchangedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 1.4m, Q3 2024 1.4m
25 MERSANA THERAPEUTICS INC COM COM 11,328,000 $21.4m1.12% 1.12% UnchangedShares held: Q4 2023 11.3m, Q1 2024 11.3m, Q2 2024 11.3m, Q3 2024 11.3m
26 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 9,000,000 $18.1m0.95% 0.95% UnchangedShares held: Q4 2023 10.4m, Q1 2024 9.0m, Q2 2024 9.0m, Q3 2024 9.0m
27 ABIVAX SA SPONSORED ADS ABVX ABVX 1,345,780 $15.5m0.81% 0.81% UnchangedShares held: Q4 2023 998.6k, Q1 2024 1.3m, Q2 2024 1.3m, Q3 2024 1.3m
28 TREVI THERAPEUTICS INC COM TRVI TRVI 3,422,656 $11.4m0.60% 0.60% AddedShares held: Q4 2023 3.4m, Q1 2024 3.4m, Q2 2024 3.4m, Q3 2024 3.4m +19 +19 0.0%
29 ARVINAS INC COM ARVN ARVN 454,450 $11.2m0.59% 0.59% ReducedShares held: Q4 2023 627.8k, Q1 2024 627.8k, Q2 2024 627.8k, Q3 2024 454.4k -173.3k -173,338 -27.6%
30 ADVERUM BIOTECHNOLOGIES INC COM NEW ADVM ADVM 1,467,048 $10.3m0.54% 0.54% UnchangedShares held: Q4 2023 0, Q1 2024 1.6m, Q2 2024 1.5m, Q3 2024 1.5m
31 CENTURY THERAPEUTICS INC COM IPSC IPSC 5,389,259 $9.2m0.48% 0.48% UnchangedShares held: Q4 2023 0, Q1 2024 3.4m, Q2 2024 5.4m, Q3 2024 5.4m
32 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 2,023,166 $8.2m0.43% 0.43% ReducedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 6.0m, Q3 2024 2.0m -4.0m -4,000,000 -66.4%
33 PERCEPTIVE CAP SOLUTIONS COR CL A ORD SHS FRNM FRNM 750,000 $7.5m0.39% 0.39% UnchangedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 750.0k, Q3 2024 750.0k
34 CABALETTA BIO INC COM CABA CABA 1,563,952 $7.4m0.39% 0.39% UnchangedShares held: Q4 2023 2.6m, Q1 2024 1.6m, Q2 2024 1.6m, Q3 2024 1.6m
35 CASI PHARMACEUTICALS INC ORD SHS CASIF CASIF 987,259 $6.1m0.32% 0.32% AddedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 111.7k, Q3 2024 987.3k +875.6k +875,573 784.0%
36 TENAYA THERAPEUTICS INC COM TNYA TNYA 1,555,556 $3.0m0.16% 0.16% UnchangedShares held: Q4 2023 0, Q1 2024 1.6m, Q2 2024 1.6m, Q3 2024 1.6m
37 INSTIL BIO INC COM NEW TIL TIL 33,177 $2.2m0.12% 0.12% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 33.2k
38 TENAX THERAPEUTICS INC COM NEW TENX TENX 208,333 $720.8k0.04% 0.04% NewShares held: Q4 2023 0, Q1 2024 0, Q2 2024 0, Q3 2024 208.3k

Sold out since Q2 2024

SecurityTickerShares held beforeValue then
ARCA BIOPHARMA INC 866,375 $3.3m866.4k shares